Neurobiology of Disease, 2023 Uncovering a neurological protein signature for severe COVID-19 El-Agnaf O., Bensmail I., Al-Nesf M. et al. Olink Target 96NeurologyInfectious DiseasesPathophysiologyPatient StratificationPlasma | | | | |
BMC Medicine, 2023 Chemotherapy-induced weight gain in early-stage breast cancer: a prospective matched cohort study reveals associations with inflammation and gut dysbiosis Walker J., Joy A., Vos L. et al. Olink Target 96OncologyMetabolic DiseasesPathophysiologyPlasma | | | | |
Clinical Rheumatology, 2023 Plasma proteomic profiling reveals KRT19 could be a potential biomarker in patients with anti-MDA5+ dermatomyositis Zhang P., Li M., Zhang Y. et al. Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma | | | | |
International Journal of Molecular Sciences, 2023 Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization Clavero E., Sanchez-Maldonado J., Macauda A. et al. Olink Target 96OncologyPathophysiologyPlasmaSerum | | | | |
Journal of Clinical Immunology, 2023 Insights into the expanding intestinal phenotypic spectrum of SOCS1 haploinsufficiency and therapeutic options Rodari M., Cazals-Hatem D., Uzzan M. et al. Olink Target 48Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
The American Journal of Human Genetics, 2023 Genome-wide aggregated trans-effects on risk of type 1 diabetes: A test of the “omnigenic” sparse effector hypothesis of complex trait genetics Iakovliev A., McGurnaghan S., Hayward C. et al. Olink Target 96Metabolic DiseasesPathophysiologyPlasma | | | | |
Frontiers in Immunology, 2023 Type 1 interferon signature in peripheral blood mononuclear cells and monocytes of idiopathic inflammatory myopathy patients with different myositis-specific autoantibodies Li M., Zhang Y., Zhang W. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Thrombosis Research, 2023 Unsupervised clustering of venous thromboembolism patients by clinical features at presentation identifies novel endotypes that improve prognostic stratification Pallares Robles A., ten Cate V., Lenz M. et al. Olink Target 96CVDPathophysiologyPatient StratificationPlasma | | | | |
Stress, 2023 The chronic stress risk phenotype mirrored in the human retina as a neurodegenerative condition Malan L., van Wyk R., von Känel R. et al. Olink Target 96NeurologyOphthalmologyPathophysiologySerum | | | | |
Scientific Reports, 2023 Age-dependent differences and similarities in the plasma proteomic signature of postoperative delirium Oren R., Kim E., Leonard A. et al. Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma | | | | |
Hepatology, 2023 Bile exosomal miR-182/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation Shu L., Li X., Liu Z. et al. Olink Target 96OncologyPathophysiologyCell Culture Supernatant | | | | |
Brain, Behavior, and Immunity, 2023 Immunological protein profiling of first-episode psychosis patients identifies CSF and blood biomarkers correlating with disease severity Eren F., Schwieler L., Orhan F. et al. Olink Target 96NeurologyPathophysiologyPatient StratificationPlasmaCSF | | | | |
JACC: Heart Failure, 2023 Myeloperoxidase Inhibition Reverses Biomarker Profiles Associated With Clinical Outcomes in HFpEF Michaëlsson E., Lund L., Hage C. et al. Olink Target 96CVDPathophysiologyPatient StratificationPlasma | | | | |
Nature Communications, 2023 Identification of biomarkers for glycaemic deterioration in type 2 diabetes Slieker R., Donnelly L., Akalestou E. et al. Olink Target 96Metabolic DiseasesPatient StratificationPlasma | | | | |
International Journal of Molecular Sciences, 2023 Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia Ehtewish H., Mesleh A., Ponirakis G. et al. Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma | | | | |
Annals of Hematology, 2023 Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects Geelen I., Gullaksen S., Ilander M. et al. Olink Target 96OncologyPathophysiology | | | | |
Science Advances, 2023 Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicity Schmidt A., Bourfiss M., Alasiri A. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Med, 2023 RNase2 is a possible trigger of acute-on-chronic inflammation leading to mRNA vaccine-associated cardiac complication Ong E., Koh C., Tng D. et al. Olink Target 48Immunological & Inflammatory DiseasesPathophysiologySerum | | | | |
ESC Heart Failure, 2023 Circulating immune checkpoints predict heart failure outcomes Screever E., Yousif L., Moslehi J. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
Arthritis & Rheumatology, 2023 Preclinical Characterization of Pharmacologic NAD+ Boosting as a Promising Therapeutic Approach in Rheumatoid Arthritis Perez‐Sanchez C., Escudero‐Contreras A., Cerdó T. et al. Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma | | | | |